Nachrichten zur Mydecine Innovations Group Inc. Aktie

SUSPENSION OF TRADING Vancouver, British Columbia, 10 October 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF)…

[image] MYDECINE ANNOUCES FILING OF AUDITED AND Q1 FINANCIAL STATEMENTS Vancouver, British Columbia, July 8, 2024— Mydecine Innovations Group Inc. (the “Company”)…

MYDECINE PROVIDES Bl-WEEKLY STATUS REPORT Vancouver, British Columbia, June 14, 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0)…

MYDECINE PROVIDES Bl-WEEKLY STATUS REPORT Vancouver, British Columbia, May 17, 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0)…

MYDECINE APPLIES FOR MANAGEMENT CEASE TRADE ORDER VANCOUVER, British Columbia, 3 May 2024 — Mydecine Innovations Group Inc. (the “Company”) (CSE:…

MYDECINE RECEIVES MANAGEMENT CEASE TRADE ORDER VANCOUVER, British Columbia, 3 May 2024— Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE:…

MYDECINE INNOVATIONS GROUP INC. ANNOUNCES RESTRUCTURING TRANSACTIONS AND ANNUAL GENERAL AND SPECIAL MEETING VANCOUVER, BC – (3 May 2024) Mydecine Innovations Group Inc.…

MYDECINE INNOVATIONS GROUP INC. ANNOUNCES SHARE FOR DEBT SETTLEMENT VANCOUVER, BC – (9 April 2024) Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE:…

MYDECINE INNOVATIONS GROUP INC. ANNOUNCES SHARE FOR DEBT SETTLEMENT VANCOUVER, BC – (21 March 2024) Mydecine Innovations Group Inc. (CSE: MYCO) (FSE:…